Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cypropofol plus alfentanil versus propofol plus alfentanil for painless gastroenteroscopy
ChiCTR2400079483Phase 4Recruiting
- Sponsor
- The First Hospital of Lanzhou University
- Start
- Jan 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol, propofol and alfentanil in None (2 arms), sponsored by The First Hospital of Lanzhou University. Primary endpoints: arterial oxygen saturation, mean arterial pressure and 1 more. Started Jan 2024; status: recruiting.
02
Drugs
ciprofolpropofolalfentanil
Beyond the preview
Go deeper on ChiCTR2400079483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079483.